AOTI, INC.
AOTI · AIM · Health Care · mcap £138m today
All announcements
-
30 Sep 262026 Interim Results
Significant progress towards obtaining Medicare coverage that will dramatically expand the growth potential for TWO2® therapy
RNS 9797696 ↗ -
27 Aug 26Proposed Topical Oxygen Therapy LCD Progress
This virtual open public meeting was intended to solicit stakeholder comments on the proposed language of the LCD ahead of its finalisation.
RNS 9742185 ↗ -
04 Aug 26Director/PDMR Shareholding - ESPP Director buys
The Company was informed on 3 August 2026, that the following purchases of AOTI, Inc. common shares were made by CSC Global1 on 3 August 2026 on behalf of certain of the Company's persons discharging managerial responsibilities ("PDMR") pursuant to the...
RNS 9704592 ↗ -
27 Jul 26
-
24 Jul 26AOTI achieves transformational milestone
AOTI achieves transformational milestone that will dramatically expand the US addressable market and growth potential for its TWO2® therapy
RNS 9685298 ↗ -
19 Jun 26Director/PDMR Shareholding – Share purchase Director buys
The Company was informed on 18 June 2026 that Mr Richard Cotton, Senior Independent Director of the Company, and Mrs Jane Cotton-Hall, bought a total of 49,110 common shares of $0.00001 in the capital of the Company ("Common Shares") through the purchase...
RNS 9626444 ↗ -
01 May 26Employee Share Purchase Plan
(AIM: AOTI), a medical technology group focused on delivering outcomes-based care at home, by more durable healing of wounds and the prevention of amputations, announces the establishment of an Employee Share Purchase Plan (ESPP).
RNS 9547989 ↗ -
27 Apr 26Real-world study of AOTI’s TWO2® therapy
Large real-world study in 3,126 patients demonstrates superior durable healing of chronic wounds with AOTI's Topical Wound Oxygen (TWO2®) therapy
RNS 9538207 ↗ -
21 Apr 262025 Annual Report and Notice of AGM
2025 Annual Report and Notice of Annual General Meeting
RNS 9529320 ↗ -
30 Mar 26
-
23 Feb 26Full Year Trading Update and Notice of Results
Full Year Trading Update and Notice of Results
RNS 9441314 ↗ -
06 Oct 25Appointment of Joint Corporate Broker
AOTI, INC., a medical technology group focused on the durable healing of wounds and prevention of amputations, is pleased to announce the appointment of Panmure Liberum Limited as Joint Corporate Broker, working alongside Peel Hunt LLP, the Company's...
RNS 9151475 ↗
Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.